
    
      The study is divided into two stages, the first stage (1-16 weeks) is the main study; the
      second stage (17-32 weeks) is the extended study. This study set up 3 groups:Jaktinib
      Hydrochloride Tablets 75mg Bid group, 100mg Bid group and a placebo control group. The
      subjects were randomly enrolled in the group 1:1:1.
    
  